These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 35994500)

  • 1. Anti-SARS-CoV-2 seroprevalence in King County, WA-Cross-sectional survey, August 2020.
    Cowgill KD; Erosheva EA; Elder A; Miljacic L; Buskin S; Duchin JS
    PLoS One; 2022; 17(8):e0272783. PubMed ID: 35994500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.
    Kugeler KJ; Podewils LJ; Alden NB; Burket TL; Kawasaki B; Biggerstaff BJ; Biggs HM; Zacks R; Foster MA; Lim T; McDonald E; Tate JE; Herlihy RK; Drobeniuc J; Cortese MM
    Public Health Rep; 2022; 137(1):128-136. PubMed ID: 34752156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
    Powell AA; Ireland G; Leeson R; Lacey A; Ford B; Poh J; Ijaz S; Shute J; Cherepanov P; Tedder R; Bottomley C; Dawe F; Mangtani P; Jones P; Nguipdop-Djomo P; Ladhani SN;
    J Infect; 2023 Apr; 86(4):361-368. PubMed ID: 36803676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.
    Bajema KL; Wiegand RE; Cuffe K; Patel SV; Iachan R; Lim T; Lee A; Moyse D; Havers FP; Harding L; Fry AM; Hall AJ; Martin K; Biel M; Deng Y; Meyer WA; Mathur M; Kyle T; Gundlapalli AV; Thornburg NJ; Petersen LR; Edens C
    JAMA Intern Med; 2021 Apr; 181(4):450-460. PubMed ID: 33231628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
    Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
    Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.
    Ristić M; Milosavljević B; Vapa S; Marković M; Petrović V
    PLoS One; 2021; 16(7):e0254516. PubMed ID: 34242377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.
    Biggs HM; Harris JB; Breakwell L; Dahlgren FS; Abedi GR; Szablewski CM; Drobeniuc J; Bustamante ND; Almendares O; Schnall AH; Gilani Z; Smith T; Gieraltowski L; Johnson JA; Bajema KL; McDavid K; Schafer IJ; Sullivan V; Punkova L; Tejada-Strop A; Amiling R; Mattison CP; Cortese MM; Ford SE; Paxton LA; Drenzek C; Tate JE;
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):965-970. PubMed ID: 32701941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
    Nkuba AN; Makiala SM; Guichet E; Tshiminyi PM; Bazitama YM; Yambayamba MK; Kazenza BM; Kabeya TM; Matungulu EB; Baketana LK; Mitongo NM; Thaurignac G; Leendertz FH; Vanlerberghe V; Pelloquin R; Etard JF; Maman D; Mbala PK; Ayouba A; Peeters M; Muyembe JT; Delaporte E; Ahuka SM
    Clin Infect Dis; 2022 Mar; 74(5):882-890. PubMed ID: 34089598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Novel Coronavirus SARS-CoV-2 at a Community Hospital Emergency Department and Outpatient Laboratory in Northern Orange County, California.
    Yamaki J; Peled H; Mathews S; Park D; Firoozi M; Smith K; Nguyen L
    J Racial Ethn Health Disparities; 2021 Dec; 8(6):1551-1555. PubMed ID: 33230735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
    Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
    JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona.
    Jehn M; Pandit U; Sabin S; Tompkins C; White J; Kaleta E; Dale AP; Ross HM; Mac McCullough J; Pepin S; Kenny K; Sanborn H; Heywood N; Schnall AH; Lant T; Sunenshine R
    Am J Public Health; 2022 Jan; 112(1):38-42. PubMed ID: 34936397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence trends of anti-SARS-CoV-2 antibodies in the adult population of the São Paulo Municipality, Brazil: Results from seven serosurveys from June 2020 to April 2022. The SoroEpi MSP Study.
    Tess BH; Turchi Martelli CM; Goi Porto Alves MC; Cortes F; Ivata Bernal RT; Vieira de Souza W; de Albuquerque Luna EJ; da Cunha Rodrigues L; Cavallari Nunes M; de Castro Reinach F; Granato CFH; Rizzatti EG; Tostes Pintão MC
    PLoS One; 2024; 19(8):e0309441. PubMed ID: 39186722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020.
    George JA; Khoza S; Mayne E; Dlamini S; Kone N; Jassat W; Chetty K; Centner CM; Pillay T; Maphayi M; Mabuza D; Maposa I; Cassim N
    S Afr Med J; 2021 Nov; 111(11):1078-1083. PubMed ID: 34949273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 antibody seroprevalence in Santa Clara County, California.
    Bendavid E; Mulaney B; Sood N; Shah S; Bromley-Dulfano R; Lai C; Weissberg Z; Saavedra-Walker R; Tedrow J; Bogan A; Kupiec T; Eichner D; Gupta R; Ioannidis JPA; Bhattacharya J
    Int J Epidemiol; 2021 May; 50(2):410-419. PubMed ID: 33615345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample.
    Han J; Baek HJ; Noh E; Yoon K; Kim JA; Ryu S; Lee KO; Park NY; Jung E; Kim S; Lee H; Hwang YS; Jung J; Lee HJ; Cho SI; Oh S; Kim M; Oh CM; Yu B; Hong YS; Kim K; Jung SJ; Han MA; Lee MS; Lee JJ; Hwangbo Y; Yim HW; Kim YM; Lee J; Lee WY; Park JH; Oh S; Jo HS; Kim H; Kang G; Nam HS; Lee JH; Oh GJ; Shin MH; Ryu S; Hwang TY; Park SW; Kim SK; Seol R; Park KS; Kim SY; Kwon JW; Kim SS; Kim B; Lee JW; Jang EY; Kim AR; Nam J; ; Lee SY; Kim DH
    Epidemiol Health; 2023; 45():e2023075. PubMed ID: 37591786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 active infection prevalence and seroprevalence in the adult population of St. Louis County.
    Goss CW; Maricque BB; Anwuri VV; Cohen RE; Donaldson K; Johnson KJ; Powderly WG; Schechtman KB; Schmidt S; Thompson JJ; Trolard AM; Wang J; Geng EH
    Ann Epidemiol; 2022 Jul; 71():31-37. PubMed ID: 35276338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California.
    Bruckner TA; Parker DM; Bartell SM; Vieira VM; Khan S; Noymer A; Drum E; Albala B; Zahn M; Boden-Albala B
    Sci Rep; 2021 Feb; 11(1):3081. PubMed ID: 33542329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.